Agilent Technologies Sponsors Duquesne University Symposium on Exposomics,
Toxicity Pathways in Human Health
Case Studies Focus on Autism, Air Quality, Chronic Disease
SANTA CLARA, Calif. -- October 11, 2013
Agilent Technologies Inc. (NYSE:A) today announced it is sponsoring a free
scientific symposium on exposomics and the etiology of disease. A panel of
scientists from Duquesne University, The Children’s Institute of Pittsburgh
and The Heinz Endowments will discuss analytical strategies for measuring how
environmental exposure impacts human health and chronic disease. The half-day
event, “Regional Perspectives to Integrate Exposure and Exposome Measurement
with Effects on Human Health,” will be held Wednesday, Oct. 16, at Duquesne.
“The human exposome initiative is a fast-growing field of research that has
captured worldwide attention and is driving a new research paradigm,” said Dr.
Anthony Macherone, symposium co-host, senior applications chemist for Agilent,
and visiting scientist at Johns Hopkins University School of Medicine. “There
is growing evidence that 70 to 90 percent of chronic human diseases result
from exposure to exogenous and endogenous chemical entities and are not
directly attributable to genetic origin.”
“Children in western Pennsylvania, for example, appear to be exposed to more
toxic chemicals than other children nationwide, and children with autism may
process these chemicals differently from other children,” added co-host Dr.
H.M. “Skip” Kingston, professor of analytical chemistry at Duquesne and
co-director of the University’s Agilent Center of Excellence for Mass
Dr. Kingston and co-researcher Dr. Scott Faber, a developmental pediatrician,
have examined environmental pollutants and autism in children and will each
conduct separate presentations at the Oct. 16 event.
With more than 20 years of experience in the fields of forensics,
biotechnology and drug discovery, Dr. Macherone has developed specialized
liquid and gas phase chromatography/mass spectrometry techniques and other
core laboratory methods for the identification and quantification of chemicals
in biological matrices.
“The exposome is comprised of an estimated 100,000 chemical entities
circulating in the human body that are outside of genetic control and may
offer insight into reducing exposure and developing pathways to personalized
medicine,” he said.
Also at the event, guest scientist Dr. Philip R. S. Johnson from The Heinz
Endowments will discuss air quality, health impacts and exposure assessment in
the Pittsburgh region. A team of Agilent scientists will present current
trends in exposomics and their multidisciplinary work in the field.
“The nascent field of exposomics may provide some of the missing pieces to
help understand disease causality by offering an integrated view of
biochemical measurements for which Agilent provides a complete set of
analytical solutions,” said Leo Bonilla, Ph.D., Agilent’s market director for
Life Science Research/Integrated Biology.
To register for the event and view the complete symposium agenda, abstracts
and speaker biographies, visit Agilent’s Environmental Exposure Science
About Agilent’s Integrated Biology Solutions
Agilent provides researchers with analytical products that span all four major
“omics” disciplines. These combined hardware/software and informatics
solutions are fueling the next generation of pathway-centric multi-omics
research and yielding valuable information about drug responses, drug
resistance, diagnostic markers, and fundamental disease/toxicity pathways. For
more information about Agilent’s complete portfolio of integrated biology
solutions, visit http://biology.chem.agilent.com.
About Duquesne University
Founded in 1878, Duquesne is consistently ranked among the nation’s top
Catholic research universities for its award-winning faculty and tradition of
academic excellence. Duquesne, a campus of more than 10,000 graduate and
undergraduate students, has been nationally recognized for its academic
programs, community service and commitment to sustainability. www.duq.edu.
Duquesne University media contacts: Rose Ravasio, (412) 396-6051, cell (412)
818-0234; and Karen Ferrick-Roman, (412) 396-1154, cell (412) 736-1877.
For more information on The Children’s Institute of Pittsburgh, visit
For more information on The Heinz Endowments, visit www.heinz.org.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company
and a technology leader in chemical analysis, life sciences, diagnostics,
electronics and communications. The company’s 20,500 employees serve customers
in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal
2012. Information about Agilent is available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and executive news
is available at www.agilent.com/go/news.
Agilent Technologies Inc.
Susan Berg, +1-408-553-7093
Press spacebar to pause and continue. Press esc to stop.